Rapid response to clinical symptoms in early psoriatic onycho‐pachydermo‐periostitis treated with infliximab

E-ISSN： 1440-0960|59|1|e78-e79

ISSN： 0004-8380

Source： AUSTRALASIAN JOURNAL OF DERMATOLOGY, Vol.59, Iss.1, 2018-02, pp. : e78-e79

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Development of bullous pemphigoid during treatment of psoriatic onycho‐pachydermo periostitis with ustekinumab

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 10, 2015-10 ,pp. : 996-998

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development of bullous pemphigoid during treatment of psoriatic onycho‐pachydermo periostitis with ustekinumab

THE JOURNAL OF DERMATOLOGY, Vol. 385-2407, Iss. 10, 2015-10 ,pp. : 996-998

John Wiley & Sons Inc

Access to resources Recommend Favorite

Analysis of Trial Data for Infliximab and Golimumab: Baseline C‐Reactive Protein Level and Prediction of Therapeutic Response in Patients With Psoriatic Arthritis

ARTHRITIS CARE AND RESEARCH, Vol. 66, Iss. 7, 2014-07 ,pp. : 1114-1118

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Triggers: An Alternative to a Rapid Response Team

By Moldenhauer Kendra Sabel Allison Chu Eugene S. Mehler Philip S.

Joint Commission Journal on Quality and Patient Safety, Vol. 35, Iss. 3, 2009-03 ,pp. : 164-174

Joint Commission Resources

Access to resources Recommend Favorite

Clinical and Pharmacological Response of Patients Treated with DBS

NEUROMODULATION: TECHNOLOGY AT THE NEURAL INTERFACE, Vol. 6, Iss. 3, 2003-07 ,pp. : 211-212

John Wiley & Sons Inc

Access to resources Recommend Favorite